Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUK Oil & Gas Regulatory News (UKOG)

Share Price Information for UK Oil & Gas (UKOG)

Share Price is delayed by 15 minutes
Get Live Data
0.0095    -0.001 (-9.52%)
Bid:
0.009
Ask:
0.01
Spread: 0.001 (11.111%)
Market Cap: £2.76m
UKOG Live PriceLast checked at - London Stock Exchange

Intraday UK Oil & Gas Share Chart

Trading update & contract win

6 May 2011 07:00

RNS Number : 0566G
Sarantel Group PLC
06 May 2011
 



6 May 2011

 

Sarantel Group PLC

 

Trading update and major contract win

 

Sarantel Group PLC, (AIM: SLG, "Sarantel"), a leading manufacturer of high-performance, miniature antennas for mobile and wireless devices, announces a trading update for the six months to 31 March 2011 and a major contract win.

 

As announced on 18 February 2011, sales in the first half of this financial year were slower than expected. This was largely due to technical issues, unrelated to Sarantel's technology, experienced by two major customers. Both of these customers have now resolved their problems and have placed orders for revenue in the second half.

 

First-half revenues were £1m (2010: £1.4m) with a net cash balance at 31 March 2011 of £0.4m and a further £166,000 tax credit received during April.

 

Excluding the two major customers referred to above, GPS unit sales volume grew 3% and revenue by 1% while military unit sales volume increased by 52% and revenue by 26%. Development revenues grew by 185%.

 

Despite the recent set backs, Sarantel continues to make very good progress with its military customers and is also in discussion with a number of large corporations about the use of its technology in consumer applications.

 

As evidence of its progress in the military market and largely as a result of the success of its previous contract program, Sarantel has been awarded a new major contract by a leading US supplier of tactical radio systems. This new contract is to develop a customised rugged GPS antenna solution for the US company's best-selling tactical radio system. Sarantel believes this contract will contribute more than $1 million in annual revenues beginning in early 2012.

 

In order to capitalise on recent successes and to build on the momentum in the business, the Board is currently seeking further funding for working capital and to finance future growth.

 

Enquiries

 

Sarantel Group PLC

01933 670 560

David Wither, Chief Executive Officer

Nicola Malyon, Chief Financial Officer

Seymour Pierce

020 7107 8000

John Cowie/Freddy Crossley, Nominated Adviser

David Banks/Paul Jewell, Corporate Broking

College Hill

020 7457 2020

Kay Larsen/Rozi Morris

 

About Sarantel - www.sarantel.com

 

Sarantel is a leader in the design of high-performance miniature antennas for portable wireless applications. Sarantel's revolutionary ceramic filtering antennas offer dramatically improved performance over existing antenna designs, resulting in a clearer signal, better range and a 90 per cent reduction in the amount of signal radiation absorbed by the body. Because of their smaller size and higher capabilities, Sarantel's antennas enable manufacturers to create innovative wireless products for the GPS, WiMax, Satellite Radio and Satellite phone markets.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGGKVKRGMZM
Date   Source Headline
14th Oct 20227:09 amRNSHigh Court upholds Loxley planning consent
6th Oct 20227:00 amRNSDirector Share Purchase
16th Sep 20227:00 amRNSTurkey Phase 2 seismic completed
13th Sep 20226:16 pmRNSHolding(s) in Company
12th Sep 20229:05 amRNSSecond Price Monitoring Extn
12th Sep 20229:00 amRNSPrice Monitoring Extension
12th Sep 20227:00 amRNSSuccessful Placing and appointment of new CFO
8th Sep 20229:05 amRNSSecond Price Monitoring Extn
8th Sep 20229:00 amRNSPrice Monitoring Extension
6th Sep 20222:00 pmRNSPrice Monitoring Extension
5th Sep 20224:41 pmRNSSecond Price Monitoring Extn
5th Sep 20224:35 pmRNSPrice Monitoring Extension
30th Aug 202211:02 amRNSDirector/PDMR Shareholding
15th Aug 202211:59 amRNSHorse Hill Update
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:35 pmRNSPrice Monitoring Extension
27th Jul 20222:00 pmRNSSuccessful Placing
25th Jul 20227:00 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSOperational Update
30th Jun 20227:05 amRNSInterim Results
30th Jun 20227:00 amRNSTurkey operational update
28th Jun 20221:40 pmRNSResult of Annual General Meeting
27th Jun 20227:00 amRNSDirector/PDMR Shareholding
8th Jun 20222:05 pmRNSSecond Price Monitoring Extn
8th Jun 20222:00 pmRNSPrice Monitoring Extension
7th Jun 20224:41 pmRNSSecond Price Monitoring Extn
7th Jun 20224:35 pmRNSPrice Monitoring Extension
7th Jun 20224:21 pmRNSSuccessful Loxley Planning Appeal Outcome
1st Jun 20227:00 amRNSNotice of AGM
30th May 20227:00 amRNSFuture hydrogen-ready energy storage project
23rd May 20227:00 amRNSDirector/PDMR Shareholding
20th May 20227:00 amRNSBB-1z discovery granted 2-year planning extension
16th May 20227:00 amRNSNSTA HH-2z recompletion consent
13th May 20227:00 amRNSOne-year work programme on PEDL137 Horse Hill
5th May 202211:05 amRNSSecond Price Monitoring Extn
5th May 202211:00 amRNSPrice Monitoring Extension
5th May 20229:05 amRNSSecond Price Monitoring Extn
5th May 20229:00 amRNSPrice Monitoring Extension
5th May 20227:00 amRNSEnvironment Agency grants full Horse Hill Permit
25th Apr 20227:00 amRNSDirector Share Purchase
20th Apr 20227:00 amRNSTurkey: Basur-Resan seismic processing completed
25th Mar 20227:00 amRNSAnnual Review and Accounts for YE 30 Sep 2021
18th Mar 20224:02 pmRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSLoxley Appeal Decision Update
8th Mar 20224:40 pmRNSSecond Price Monitoring Extn
8th Mar 20224:35 pmRNSPrice Monitoring Extension
8th Mar 202211:00 amRNSPrice Monitoring Extension
24th Feb 20222:06 pmRNSSecond Price Monitoring Extn
24th Feb 20222:00 pmRNSPrice Monitoring Extension
21st Feb 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.